FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Compounders Sue FDA Over Semaglutide Shortages

[ Price : $8.95]

Drug compounding operations sue FDA in northern Texas federal court, seeking an order to reverse the agency decision last week to ...

Invivyd EUA Request to Expand Covid Therapy Denied

[ Price : $8.95]

FDA rejects an Invivyd request to expand the existing emergency use authorization for pre-exposure prophylaxis of Covid-19 EUA for...

Wegovy, Ozempic Shortages Resolved: FDA

[ Price : $8.95]

FDA says semaglutide injection product shortages (Novo Nordisks Wegovy and Ozempic) are resolved.

Pfizer Drops Hemophilia B Gene Therapy

[ Price : $8.95]

Pfizer discontinues the marketing of its hemophilia B gene therapy Beqvez (fidanacogene elaparvovec-dzkt) due to limited patient a...

Boehringer NDA for Lung Cancer

[ Price : $8.95]

FDA accepts for priority review a Boehringer Ingelheim NDA for zongertinib (BI 1810631) for treating certain adult patients with u...

Mirums Ctexli Approved for Rare Lipid Disease

[ Price : $8.95]

FDA approves a Mirum Pharmaceuticals NDA for Ctexli (chenodiol) for treating adults with cerebrotendinous xanthomatosis.

PhRMA Suggests Revisions to Cell Therapy Guide

[ Price : $8.95]

Pharmaceutical Research and Manufacturers of America says FDA should revise its recommendations for sponsors requesting meetings c...

FDA Staff Exodus Deepens as CBER Deputy Witten Quits

[ Price : $8.95]

In another blow to FDAs institutional knowledge, CBER deputy director Celia M. Witten leaves the agency amid a deepening staff exo...

Increased Foreign Company Enforcement Likely: Attorneys

[ Price : $8.95]

Three Arnall Golden Gregory attorneys describe steps foreign drug and medical device companies can take to prepare for what they s...

Robert Foster Named FDA Chief Counsel

[ Price : $8.95]

HHS appoints Robert Fox Foster as FDAs next chief counsel.